GREGORY RYAN SUTTON M.D. NPI 1255575270

NPI Information

  • NPI: 1255575270
  • Provider Name: GREGORY RYAN SUTTON, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2200 E 3RD ST
    SUITE 100
    CHATTANOOGA, TN
    ZIP 37404
  • Phone: (423) 698-1844

Map and Directions

Get Directions

NPI Details

Gregory Ryan Sutton, M.D. is a hematology and oncology internal medicine in Chattanooga, TN with 17 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Gregory Ryan Sutton, M.D. NPI is 1255575270. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Graduation Year:2009

The provider's business location address is:

2200 E 3RD ST
SUITE 100
CHATTANOOGA, TN
ZIP 37404-744
Phone: (423) 698-1844
Fax: (423) 624-2226

The NPI 1255575270 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, etoposide, 10 mg (HCPCS:J9181)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Protein measurement, serum (HCPCS:84165)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Automated urinalysis test (HCPCS:81003)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Magnesium level (HCPCS:83735)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Vitamin d-3 level (HCPCS:82306)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Stool analysis for blood, by peroxidase activity (HCPCS:82272)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Uric acid level, blood (HCPCS:84550)
  • Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Red blood count, automated test (HCPCS:85045)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Total protein level, blood (HCPCS:84155)

The enumeration date for this NPI number is 4/21/2009 and was last updated on 5/22/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology47962TENNESSEEYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.